Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Gliosarcoma 11Glioblastoma 11Prostatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Brain Neoplasms 4Astrocytoma 4Adenocarcinoma of Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pinealoma 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malignant mesenchymal tumor 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Glioma 2Fibrosarcoma 2Ependymoma 2

Interventions

pembrolizumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Extensive Stage Small Cell Lung Carcinoma × Radiotherapy, Conformal × Clear all
NCT02635009 2026-05-19

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

NRG Oncology

Phase 2/3 Completed
418 enrolled 52 charts
Thoracic

Extensive Stage Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡